Active ingredients
PEG-12 DIMETHICONE CROSSPOLYMER 0.86%
ARGININE 0.01%
ACETYL HEXAPEPTIDE-8 0.1%
PEG-12 DIMETHICONE CROSSPOLYMER 0.86%
ARGININE 0.01%
ACETYL HEXAPEPTIDE-8 0.1%
Face serum
Improve dry and rough,Reduced facial wrinkles,Facial Contour Firming,Significantly smoother and brighter skin,improves skin elasticity and skin texture.
After facial cleaning, apply appropriate amount
of this product,pat it to the face and massage till
fully absorbed.
1. For external use only.
2. Please do a skin test before use.
3. Avoid contact with eyes,if gets into eyes and stinning occurs,rinse thoroughly with warm water.
4. If allergic occurs, discontinue use and seek medical attention.
5. Keep out of reach of children.
allergic occurs
on damaged or broken skin
Avoid contact with eyes,,rinse thoroughly with warm water.
If swallowed, get medical help or contact a Poison Control Center right away.
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| 1681bc73-b05f-12c3-1075-382ae39f449c | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 84854-005-01 | JOCMELUAP | 30 g in 1 BOTTLE | LIQUID | 30 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 84854-005 | 84854-005-01 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 28567e43-f37e-dc67-e063-6394a90ae42c | 28567e43-f37d-dc67-e063-6394a90ae42c | 2024-12-02 | Warnings | 28567e43-f37e-dc67-e063-6394a90ae42c 28567e43-f37d-dc67-e063-6394a90ae42c |
Adverse event summaries are temporarily unavailable. Other product information remains available.